BenevolentAI | Investor Day Presentation Deck

Slide schematic 6/6

callout 2/2 diagram 1/1 list 2/2 title 1/1

Components 6

primary primary process bullet bullet headline

Tools 1

list/bullet: Repurposing a target or drug (approved or in development) through the identification of additional disease indications: Address additional unmet need, Maximise the value of a target or drug programme

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

process 80%

The slide depicts a linear drug development pipeline with integrated feedback loops.

Find anything

The slide uses a process flow diagram to illustrate the integration of AI-driven precision medicine into the standard pharmaceutical R&D lifecycle.